Breast cancer remains a leading cause of cancer-related deaths among women worldwide. Conventional treatments face challenges such as toxicity, low specificity, and drug resistance. Nanotechnology offers innovative solutions through targeted and controlled drug delivery. Recent advances focus on passive and active targeting strategies for enhanced efficacy. Different nano carriers—lipid-based, polymeric, inorganic, and hybrid—are being developed. Stimuli-responsive and multifunctional nanoparticle enable combined therapy and diagnosis. Key challenges include scalability, toxicity and regulatory hurdles in clinical translation. Future trends emphasize precision nano medicine to improve breast cancer treatment outcomes.
KEERTHI et al. (Thu,) studied this question.